Publication | Closed Access

Basal 18 F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer

Positron Emission TomographyAdvanced Breast CancerNuclear MedicineEngineeringOncologic ImagingMedical ImagingCancer DetectionBreast OncologyBreast ImagingBreast CancerBasal 18F-fluoro-2-deoxy-d-glucose Positron EmissionOncologyRadiation OncologyMolecular ImagingRadiologyHealth Sciences